ClinicalTrials.Veeva

Menu

Keratoconus Detection by Ultrasound

Columbia University logo

Columbia University

Status

Completed

Conditions

Keratoconus

Treatments

Procedure: Artemis Ultrasound Exam
Procedure: Optical Coherence Tomography (OCT) Exam

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT01403129
AAAF1497
R01EY019055 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Keratoconus (KC) is a corneal disease which will in many cases ultimately require corneal transplantation to maintain vision. Early detection, which is not possible with current technology, would allow early treatment and prevent severe damage to KC corneas inadvertently operated upon for correction of vision. The investigators' aim is to combine measurements of different properties of the cornea to develop means for early detection of KC.

Full description

Keratoconus is the most common degenerative disease affecting the cornea. As keratoconus develops, the cornea thins and bulges. Eventually, a corneal transplant may be needed to maintain vision. In its earliest stages, the disease is particularly difficult to detect. This is of great importance to the corneal refractive surgeon because surgical treatment of a keratoconic cornea will weaken it and greatly accelerate the occurrence of symptoms. Early detection of keratoconus will benefit patients because of the recent development of methods for strengthening the corneal stroma and preventing disease progression.

The investigators have developed a technique based on the use of high resolution ultrasound for imaging the cornea and measuring the thickness of its component layers, including the epithelium and the stroma. In early keratoconus, as the anterior stromal surface begins to bulge forward, the epithelium will thin above the apex of the bulge and thicken around it, to maintain a smooth anterior surface. The investigators have also developed methods for characterizing the elastic properties of the cornea by inducing and measuring surface displacements in response to a pulse of acoustic radiation force.

The investigators' goal is to reduce the percentage of screened cases deemed keratoconus-suspect by at least a factor of two by allowing an unambiguous diagnosis of early keratoconus. This would provide two major benefits; (1) to be able to predict eyes with higher risk of developing ectasia after corneal refractive surgery, and (2) early diagnosis would allow earlier treatment of the condition with collagen crosslinking, preserving the cornea from disease progression.

Enrollment

250 estimated patients

Sex

All

Ages

6 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of keratoconus (KC) or keratoconus-suspect
  • Blood relation of person with KC
  • Age-matched normal of KC subjects
  • Ability to sit still in front of ultrasound unit and lie on exam table

Exclusion criteria

  • Other eye disease

Trial design

250 participants in 3 patient groups

Keratoconus-Suspect
Description:
A person who has or is suspected of having keratoconus. Will have either or both Artemis-2 exam and OCT exam.
Treatment:
Procedure: Optical Coherence Tomography (OCT) Exam
Procedure: Artemis Ultrasound Exam
Keratoconus-Related
Description:
A person who is genetically related to someone with keratoconus. Will have either or both Artemis-2 exam and OCT exam.
Treatment:
Procedure: Optical Coherence Tomography (OCT) Exam
Procedure: Artemis Ultrasound Exam
Age-Matched Normal
Description:
A person who is approximately the same age as subjects who have been enrolled in the study. Will have either or both Artemis-2 exam and OCT exam.
Treatment:
Procedure: Optical Coherence Tomography (OCT) Exam
Procedure: Artemis Ultrasound Exam

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems